NLS Acquisition

Acquisition - May 22, 2013

Actavis in billion dollar deal

Generic drug maker Actavis Inc recently announced the purchase of specialty pharmaceutical company Warner Chilcott Plc. Under the agreement, Actavis will acquire Warner Chilcott  in a stock-for-stock transaction valued at approximately $8.5 billion. If successfully completed, the transaction will create a global specialty pharmaceutical company with approximately $11 billion in combined annual revenue, states Actavis […]

Acquisition - May 20, 2013

Synteract acquires Harrison Clinical Research

The Carlsbad, CA-based contract research organization (CRO) Synteract has acquired the international CRO Munich-based company Harrison Clinical Research. The company will now act globally as SynteractHCR, with offices in Western and Eastern Europe, Israel, Russia, South America, and the U.S. The new company says it will be a top-tier service provider with the scale to […]

Acquisition - May 20, 2013

TFS acquires Beardsworth Consulting Group

On April 26th TFS International (TFS) completed the acquisition of the New Jersey-based Oncology and Vaccine specialist Contract Research Organization (CRO), Beardsworth Consulting Group, Inc. (BCG). In a move to expand its oncology and vaccine research services, TFS has announced the completion of acquiring BCG, an independent clinical CRO with headquarters in Flemington, New Jersey, […]

Acquisition - April 29, 2013

Vitrolife acquires HertArt

Swedish Vitrolife has acquired all the shares in Danish company HertArt ApS.

Acquisition - April 29, 2013

Multi-million dollar contract for Bavarian Nordic

Danish Bavarian Nordic receives contract valued up to USD 228 Million from the U.S. Government.

Acquisition - April 16, 2013

Investor acquires Permobil

The Swedish Investment company Investor has acquired the medtech company Permobil, a global leader in advanced powered wheelchairs. The Timrå-based company was acquired from Nordic Capital Fund V for an enterprise value of SEK 5.1 billion. In 2012 sales and EBITDA (pro forma for acquired units) amounted to approximately SEK 1.6 billion and SEK 350 […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.